According to another pooled analysis of 427 gTP53 carriers who underwent multi-gene panel testing and 154 gTP53 carriers with TP53 single-gene testing, carriers of truncated and hotspot variants tended to present with LFS cancers and had a shorter time to first cancer diagnosis than carriers of missense variants [29]. This evidence concerns the gene TP53 and cancer.